- Home
- EBMT vs VXRT Comparison
EBMT vs VXRT Comparison
Compare EBMT & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- VXRT
- Stock Information
- Founded
- EBMT 1922
- VXRT N/A
- Country
- EBMT United States
- VXRT United States
- Employees
- EBMT N/A
- VXRT N/A
- Industry
- EBMT Major Banks
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EBMT Finance
- VXRT Health Care
- Exchange
- EBMT Nasdaq
- VXRT Nasdaq
- Market Cap
- EBMT 141.1M
- VXRT 119.0M
- IPO Year
- EBMT N/A
- VXRT N/A
- Fundamental
- Price
- EBMT $16.75
- VXRT $0.42
- Analyst Decision
- EBMT
- VXRT Strong Buy
- Analyst Count
- EBMT 0
- VXRT 2
- Target Price
- EBMT N/A
- VXRT $3.00
- AVG Volume (30 Days)
- EBMT 38.9K
- VXRT 1.8M
- Earning Date
- EBMT 07-22-2025
- VXRT 05-13-2025
- Dividend Yield
- EBMT 3.41%
- VXRT N/A
- EPS Growth
- EBMT 26.99
- VXRT N/A
- EPS
- EBMT 1.41
- VXRT N/A
- Revenue
- EBMT $82,271,000.00
- VXRT $47,395,000.00
- Revenue This Year
- EBMT N/A
- VXRT N/A
- Revenue Next Year
- EBMT $4.97
- VXRT N/A
- P/E Ratio
- EBMT $11.86
- VXRT N/A
- Revenue Growth
- EBMT 0.06
- VXRT 433.43
- 52 Week Low
- EBMT $12.61
- VXRT $0.29
- 52 Week High
- EBMT $18.49
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- EBMT 40.23
- VXRT 46.21
- Support Level
- EBMT $16.75
- VXRT $0.42
- Resistance Level
- EBMT $17.18
- VXRT $0.48
- Average True Range (ATR)
- EBMT 0.34
- VXRT 0.04
- MACD
- EBMT -0.10
- VXRT -0.00
- Stochastic Oscillator
- EBMT 8.70
- VXRT 17.87
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.